![[img]](https://epub.uni-regensburg.de/style/images/fileicons/application_pdf.png) | Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (974kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-770250
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.77025
Zusammenfassung
Immune-related adverse events (irAE) are common in checkpoint blockade–treated patients and limit its clinical application. Corticosteroids are the first-line therapy for treatment of irAE, but animal models clearly demonstrate that steroids diminish anti-programmed cell death protein 1 (PD-1)-induced tumour immunity. Better strategies to manage irAE while preserving anti-tumour immunity are ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik